Company Description
Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States.
The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation; and delivers a binary prediction on the wounds capacity to heal or not heal by a specified time point in the future to assist the physician in making a more accurate, timely, and informed decision regarding the treatment of the patient’s wounds.
Its system also includes MSI imaging technology, which consists of proprietary multi-spectral optics and sensors that capture injured tissue images; and AI-Burn software.
Spectral AI, Inc. is headquartered in Dallas, Texas.
Contact Details
Address: 2515 McKinney Avenue, Suite 1000 Dallas, Texas 75201 United States | |
| Phone | 972 499 4934 |
| Website | spectral-ai.com |
Stock Details
| Ticker Symbol | MDAIW |
| Exchange | NASDAQ |
| Stock Type | Warrants |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US84757T1051 |
Key Executives
| Name | Position |
|---|---|
| Wensheng Fan | Co-Founder, Chief Innovation Strategist and Senior Advisor to the Chief Executive Officer |
| Dr. John Michael DiMaio M.D. | Founder and Chairman |
| Vincent Stanley Capone Esq. | Chief Financial Officer, General Counsel and Corporate Secretary |
| Stanley Micek | Chief Operating Officer |
| Jeremiah A. Sparks MBA | Chief Commercialization Officer |
| Louis Percoco | General Manager |
| Prof. Paul Chadwick | Executive Vice President of UK and EMEA |